Your browser doesn't support javascript.
loading
Sacituzumab govitecan: a promising antibody-drug conjugate for the treatment of poorly differentiated endometrial cancer.
Webster, Emily M; Zeybek, Burak; Tymon-Rosario, Joan; Santin, Alessandro D.
Afiliação
  • Webster EM; Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Gynecologic Oncology, Yale School of Medicine, New Haven, CT, USA.
  • Zeybek B; Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Gynecologic Oncology, Yale School of Medicine, New Haven, CT, USA.
  • Tymon-Rosario J; Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Gynecologic Oncology, Yale School of Medicine, New Haven, CT, USA.
  • Santin AD; Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Gynecologic Oncology, Yale School of Medicine, New Haven, CT, USA.
Oncoscience ; 7(9-10): 68-69, 2020 Sep.
Article em En | MEDLINE | ID: mdl-33195736
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Oncoscience Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Oncoscience Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos